Drug & medication recalls Moderate risk

Sandoz product recalled over manufacturing violations

Recall date
September 23, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Sandoz, Inc recalls Sandoz Ranitidine Hydrochloride Capsules 150mg 60 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ Product of…
Recall number
D-0127-2020
FDA classification
Class II
Brand / firm
Sandoz, Inc
Sold / distributed
U.S. Nationwide

Why it was recalled

CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Sandoz Ranitidine Hydrochloride Capsules 150mg 60 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ Product of India NDC 0781-2855-60

Get recall alerts

Free email alert whenever Sandoz, Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Sandoz, Inc